Viewing Study NCT01300793


Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2026-05-17 @ 9:52 AM
Study NCT ID: NCT01300793
Status: TERMINATED
Last Update Posted: 2012-09-26
First Post: 2009-09-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide
Sponsor: University of California, San Francisco
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Hodgkin's Lymphoma View
None B-cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None V-RICE View
None Relapsed NHL View
None Primary Refractory NHL View